PureCycle Making Waves with Successful UPR Resin Production; La-Z-Boy's Sales Outlook Falls Short
- June 20th, 2023
- 320 views
Shares of PureCycle Technologies, Inc. (Nasdaq: PCT) experienced a significant surge of over 10% in after-hours trading Tuesday following the successful production of the first run of Ultra-Pure Recycled (UPR) resin from post-industrial recycled material at commercial scale.
This achievement marks a significant milestone in the operation of PureCycle's flagship polypropylene purification facility in Ironton, Ohio. Once fully operational, the Ironton facility is expected to have an annual production capacity of 107 million pounds of UPR resin.
PureCycle's technology offers a solution to the challenges of recycling polypropylene, as it can effectively purify various shapes, sizes, and contaminants typically present in waste polypropylene.
In after-hours, $PCT is currently trading at $8.80, reflecting a gain of $0.86 (+10.83%).
La-Z-Boy Incorporated (NYSE: LZB) reported fourth-quarter fiscal 2023 earnings per share (EPS) of $0.99, surpassing the consensus estimate of $0.72.
However, the company anticipates a challenging start to the first quarter of fiscal 2024, which typically represents its lowest sales quarter. La-Z-Boy expects sales in the range of $470 million to $490 million, falling short of the consensus revenue estimate of $522.45 million for the period.
$LZB is trading at $26.35 in after-hours, down $1.11 (-4.04%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Johnson & Johnson, Charles Schwab, Halliburton: Earnings Preview
January 18th, 2026Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026




Member Login